Sandoz gains significant capabilities and assets in medical and drug device development that target major growth opportunities in respiratory and…
Agreement sharpens AstraZeneca’s focus on priority medicines in Respiratory & Immunology portfolio (PRESS RELEASE) CAMBRIDGE, 1-Nov-2021 — /EuropaWire/ — AstraZeneca…